Ignite Creation Date:
2025-12-24 @ 11:32 PM
Ignite Modification Date:
2025-12-25 @ 9:20 PM
Study NCT ID:
NCT01551056
Status:
COMPLETED
Last Update Posted:
2017-11-07
First Post:
2012-03-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC)
Sponsor:
Aciex Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-03
Start Date Type:
None
Primary Completion Date:
2012-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-06
Completion Date Type:
ACTUAL
First Submit Date:
2012-03-08
First Submit QC Date:
None
Study First Post Date:
2012-03-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-06-27
Results First Submit QC Date:
None
Results First Post Date:
2017-10-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-05-19
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-10-06
Last Update Post Date:
2017-11-07
Last Update Post Date Type:
ACTUAL